Quarterly report · Q2
4320.TEDINET S100QQ1L
Period2022-10-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.3bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥13.7bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.2bn | 2021-10-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥840m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥616m | 2021-10-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥838m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥621m | 2021-10-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥861m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥621m | 2021-10-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥495m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥588m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥336m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥536m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥378m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥11.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥10.9bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥11.4bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.9bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥4.8bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.1bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.8bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥289m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥254m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥764m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥891m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥194m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥307m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥535m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥32.99 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.5 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.13 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.38 | 2021-10-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.85 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 52.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥26m |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥873m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥8m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥7.3bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥7.3bn |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥865m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | −¥60m |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥681m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥19m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥19m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥5m |
| —segment total | revenue | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| —segment total | revenue external | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| —segment total | segment profit | 2021-10-01 → 2022-03-31 | ¥676m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 478
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人シドー | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)菅井 朗 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)政近 克幸 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 7233223000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 7341341000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 13702572000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 620725000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 837571000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1044328000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 335602000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 494855000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 588002000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 371902000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 546794000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 661269000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 5792741000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 6348112000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 6082108000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 11368448000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 11204607000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 10905398000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 22.38 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 32.99 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 39.13 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.474 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.526 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.516 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 1476170000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | -288894000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1550678000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -891070000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -254093000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -763830000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 534778000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -193970000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 306644000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 3984907000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 3221562000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 3958521000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 21.85 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 26.50 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 15347600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 15347600 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 15347600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 15347600 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |